StreetAccount Summary - European unusual volume traders
StreetAccount Summary - US Pre-market trading update
StreetAccount Summary - Trading higher/lower: EU mid-morning
DBV Technologies announces first subject screened in COMFORT toddlers supplemental safety study in peanut allergic toddlers 1-3 years old (€1.50, 0.00)
Goldman Sachs reinstates DBV.FP, DBVT
StreetAccount Sector Summary - Healthcare Pre-Market
DBV Technologies initiated outperform at LifeSci Capital ($8.77, 0.00)
StreetAccount Summary - US unusual volume traders
Powered by FactSet Research Systems Inc.